KRT19 and intrahepatic cholangiocarcinoma: Given the predominant expression of CK19 in chronic biliary tract disease and the absence of CK19 in hepatocytes (36, 37), CYFRA21–1 levels are expected to be greater in ICC than in HCC, a hypothesis supported by our study.